Skip to main content
Signal8

DEFJ, LLC

SEC insider (Form 3/4/5 filer). CIK 0002147448. 10% Owner at Transcode Therapeutics, Inc. (RNAZ). 2 reported Form 4/5 transactions since Sep 2024; latest on Aug 3, 2026. Located in CENTRAL HONG KONG.

Companies DEFJ, LLC has filed insider reports for

  • Transcode Therapeutics, Inc. (RNAZ): 10% Owner
DEFJ, LLC profile photo

DEFJ, LLC

CIK: 0002147448

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (100.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Transcode Therapeutics, Inc. logo
RNAZ

Transcode Therapeutics, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Transcode Therapeutics, Inc. logo
    RNAZ

    Transcode Therapeutics, Inc.

    Aug 3, 2026
    Conversion
    Direct
    11.8M shares-
  • Transcode Therapeutics, Inc. logo
    RNAZ

    Transcode Therapeutics, Inc.

    Aug 3, 2026
    Conversion
    Direct
    2M shares-

1-2 of 2